{"schema_version":"secwatch.filing_event.v1","accession":"0001554795-24-000051","form_type":"8-K/A","ticker":null,"cik":"0001118072","company_name":"SKINOVATION PHARMACEUTICAL INC","filed_at":"2024-03-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.438085+00:00","generated_at":"2026-06-04T22:47:41.011641+00:00","sec_items":["4.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Skinovation changes auditor: dismisses Pinnacle, appoints Fruci & Associates","bullets":["Board dismissed Pinnacle Accountancy Group and engaged Fruci & Associates II, PLLC effective January 3, 2024.","Pinnacle's reports for fiscal years ended Dec 31, 2022 and 2021 contained no adverse opinion or qualification.","No disagreements with Pinnacle on accounting principles or audit scope during the relevant periods.","Filing is an amendment to correct the name of the new audit firm."],"urls":{"canonical":"https://secwatch.observer/filing/0001554795-24-000051","json":"https://secwatch.observer/filing/0001554795-24-000051.json","markdown":"https://secwatch.observer/filing/0001554795-24-000051.md","text":"https://secwatch.observer/filing/0001554795-24-000051.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1118072/000155479524000051/0001554795-24-000051-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1118072/000155479524000051/skin0312form8ka1.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T22:47:41.011641+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9421b7444f7507132d46ba4ad785bb7f8fe242e2","claim":"SKINOVATION PHARMACEUTICAL INC engaged Fruci & Associates II, PLLC as its auditor.","evidence_excerpt":"Also on January 3, 2024, the Company engaged the accounting firm of Fruci & Associates II, PLLC as the Company’s new independent registered public accounting firm.","evidence_source":"SEC 8-K Item 4.01/4.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1118072/000155479524000051/0001554795-24-000051-index.htm","confidence":0.9,"family_label":"Auditor Changes","details":[{"label":"Action","value":"engagement"},{"label":"Auditor","value":"Fruci & Associates II, PLLC"}],"fact_type":"auditor_change"},{"claim_id":"ffa5c58ede8f9205191a6e2d25706504f4dbb7c9","claim":"SKINOVATION PHARMACEUTICAL INC dismissed Pinnacle Accountancy Group of Utah as its auditor.","evidence_excerpt":"On January 3, 2024, the Board of Directors (the “Board”) of Skinovation Pharmaceutical Incorporated (“Skinovation” or the “Company”) agreed to dismiss the Company’s independent registered public accounting firm, Pinnacle Accountancy Group of Utah (“Pinnacle”), effective as of January 3, 2024.","evidence_source":"SEC 8-K Item 4.01/4.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1118072/000155479524000051/0001554795-24-000051-index.htm","confidence":0.9,"family_label":"Auditor Changes","details":[{"label":"Action","value":"dismissal"},{"label":"Auditor","value":"Pinnacle Accountancy Group of Utah"},{"label":"Successor","value":"Fruci & Associates II, PLLC"}],"fact_type":"auditor_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}